CUSIP: 698340106
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,620,891
-
Share change
-
-5,475
-
Total reported value
-
$157,727,000
-
Price per share
-
$14.85
-
Number of holders
-
47
-
Value change
-
+$4,349,694
-
Number of buys
-
30
-
Number of sells
-
21
Quarterly Holders Quick Answers
What is CUSIP 698340106?
CUSIP 698340106 identifies PAND - PANDION THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of PANDION THERAPEUTICS INC - COM (PAND) as of Q4 2020
As of 31 Dec 2020,
PANDION THERAPEUTICS INC - COM (PAND) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,620,891 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Redmile Group, LLC, FEDERATED HERMES, INC., BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, FMR LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.